Marksans Pharma shines on getting UK MHRA’s approval for Goa plant

10 May 2017 Evaluate

Marksans Pharma is currently trading at Rs. 53.95, up by 5.80 points or 12.05% from its previous closing of Rs. 48.15 on the BSE.

The scrip opened at Rs. 49.20 and has touched a high and low of Rs. 56.25 and Rs. 48.20 respectively. So far 3631677 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 58.30 on 04-Oct-2016 and a 52 week low of Rs. 36.95 on 01-Feb-2017.

Last one week high and low of the scrip stood at Rs. 56.25 and Rs. 47.60 respectively. The current market cap of the company is Rs. 2202.11 crore.

The promoters holding in the company stood at 48.25%, while Institutions and Non-Institutions held 8.63% and 43.12% respectively.

Marksans Pharma’s Goa plant has been approved by UK Medicines and Healthcare products Regulatory Agency (UK MHRA). The UK’s healthcare regulator inspected the company’s Goa plant from February 14- February 17.

Marksans Pharma is engaged in production of prescription drugs, caters in areas like oncology, gastroenterology, antidiabetic, cardiovascular, pain management, gynaecology and others.

Marksans Pharma Share Price

166.55 1.95 (1.18%)
28-May-2024 15:31 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1464.85
Dr. Reddys Lab 5955.65
Cipla 1477.15
Zydus Lifesciences 1050.35
Lupin 1603.55
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.